Malvern Instruments Viscotek SEC-MALS 20 Launch Goes Online
Recordings of Malvern Instruments’ July 25th launch of the Viscotek SEC-MALS 20 multiple angle light scattering (MALS) detector can now be viewed online. With this extension to its range of GPC/SEC detectors, Malvern becomes the only vendor to offer all types of static light scattering detector routinely used for absolute molecular weight measurement. The full launch webinar is available at www.malvern.com/secmals20launch and a 3-minute video that gives a basic introduction to the new system is available on YouTube at http://bit.ly/SEC-MALS20
Static light scattering is widely used within gel permeation/size exclusion chromatography (GPC/SEC) for the determination of the absolute molecular weight of protein, polymer and macromolecular species without the need for external, potentially inaccurate calibrations.
The new Viscotek SEC-MALS 20 offers numerous operational features that increase both accuracy and operational ease of use. Not only does it incorporate more detectors than any other commercial alternative, the increased detection at lower angles provides a significant improvement in accuracy compared with other MALS systems, even at high molecular weights. In addition, the new vertical, as opposed to lateral, sample flow cell with radial optics allows the use of a variety of mobile phase solvents, without the need for optical readjustment.
Malvern’s static light scattering detectors, which include low angle, right angle and multi angle detectors, are available individually and are compatible with any commercial GPC/SEC system, or may be supplied integrated within a multi detection Viscotek system for comprehensive polymer, protein, and macromolecule characterisation.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance